SCHEMBL29119487

SCHEMBL29119487

CC(=O)Nc1ccc2c(c1)CCN(C1CC1)CC2

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 3/20 0.59
NPC1 O15118 2/20 0.47
CYP1A2 P05177 1/20 0.47
ADRA2A P08913 1/20 0.47
MAOA P21397 1/20 0.47
SLC6A2 P23975 1/20 0.47
HTR2C P28335 1/20 0.47
SLC6A4 P31645 1/20 0.47
HTR2B P41595 1/20 0.47
RAB9A P51151 1/20 0.47
HTR1A P08908 2/20 0.46
HTR2A P28223 1/20 0.46
BAZ2B Q9UIF8 1/20 0.46
HTR1D P28221 1/20 0.45
HTR1B P28222 1/20 0.45
HTR1F P30939 1/20 0.45
MTNR1A P48039 1/20 0.45
ALDH1A1 P00352 2/20 0.45
KDM4E B2RXH2 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4772402 0.94 HRH3 (0.66) HRH3NPC1RAB9ABAZ2BALDH1A1
SCHEMBL4591071 0.83 NPC1 (0.53) NPC1CYP1A2ADRA2AMAOASLC6A2
SCHEMBL8252690 0.83 NPC1 (0.45) HRH3NPC1CYP1A2RAB9AALDH1A1
SCHEMBL5459684 0.82 HRH3 (0.53) HRH3NPC1CYP1A2RAB9ASMN1; SMN2
SCHEMBL18949229 0.80 HRH3 (0.46) HRH3MLNR
SCHEMBL4768153 0.80 LMNA (0.56) HRH3NPC1RAB9AALDH1A1KDM4E
SCHEMBL4774168 0.79 HRH3 (0.53) HRH3NPC1RAB9AMLNR
SCHEMBL4771050 0.79 CYP3A4 (0.56) HRH3NPC1RAB9AL3MBTL1SMN1; SMN2
SCHEMBL29119496 0.78 MLNR (0.51) NPC1CYP1A2ADRA2AMAOASLC6A2
SCHEMBL29119510 0.78 BAZ2B (0.54) NPC1RAB9ABAZ2BALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116888127-A Tri-fused ring HPK1 inhibitor and application thereof 轩竹生物科技股份有限公司 2023-10-13 CN disclosed
WO-2022188823-A1 TRICYCLIC HPK1 INHIBITOR AND USE THEREOF 山东轩竹医药科技有限公司 2022-09-15 WO disclosed